China COVID-19 diagnostics market will see declined growth of 25.1% during the forecast period. China has a significant market share in the global COVID-19 diagnostic market owing to the growing number of diagnostic screening in the country coupled with government initiatives for providing rapid screening for COVID-19. Moreover, the introduction of advanced and early diagnostic tests in the country further propels the growth of the market. For instance, in February 2020, the Government of China opened a 2,000 square-meter emergency detection laboratory called Huoyan in Wuhan City which can process over 10,000 samples a day.
Browse the full report description of "China COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-User (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026" at https://www.omrglobal.com/industry-reports/china-covid-19-diagnostics-market
In April 2020, Sansure Biotech, Inc. developed a fast COVID-19 nucleic acid testing system and approved by the NMPA that does not require a professional laboratory and gives a test result within 15-45 minutes. The Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is a real-time reverse transcription-polymerase chain reaction (rRT-PCR) test. The 2019-nCoV primer and probe set(s) is designed to detect RNA from SARS-CoV-2 in respiratory specimens from patients with signs and symptoms of infection who are suspected of COVID-19. Therefore, these advancements in the diagnostics kit for COVID-19 further provide significant growth in the market.
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2020-2026 |
|
Segments Covered |
By Type, By Technology Type, By Sample Type, and By End-Users |
|
Key Companies Profiled |
BGI Group, Da An Gene Co., Ltd., Maccura Biotechnology Co., Ltd.,
Sansure Biotech Inc., and Guangzhou Wondfo Biotech Co., Ltd. |
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID -19
o Most affected segment
o Recommendations
China COVID-19 Diagnostics Market – Segmentation
By Type
By Technology Type
o Chromatographic Immunoassay
o Fluorescent Immunoassay
o Chemiluminescent Immunoassay
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Neutralization
o Chemiluminescent Immunoassay
By Sample Type
By End-Users
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/china-covid-19-diagnostics-market